Latest
By Staff Report / Tuesday, August 4th, 2015 / Central Coast Health Watch, Latest news, Technology, Top Stories, Tri-County Public Companies / Comments Off on Shire makes $30 billion bid for Thousands Oaks’ Baxalta
One of the biggest employers in Ventura County faces an ownership change less than one month after it was spun off from its Chicago-area parent. Shire Plc, a pharma company based in Dublin, Ireland, stunned the markets on Aug. 4 with a $30 billion bid for Baxalta. Baxalta, which employs around 2,000 at two locations Read More →
Read More →
Latest
By Henry Dubroff / Friday, July 31st, 2015 / Central Coast Health Watch, Editorials, Opinion / Comments Off on Economic development should be part of Ventura County’s general plan
Ventura County is embarking on an important step forward as it weighs the latest update to its general plan. That step would be to include an economic development element to the general plan in the next approval cycle. A letter to county officials from the Economic Development Collaborative of Ventura County recommends the county include Read More →
Read More →
Latest
By Manny Araujo / Friday, July 31st, 2015 / Central Coast Health Watch, Small Business / Comments Off on Help Unlimited celebrates 40 years of pairing caregivers with patients
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →
Latest
By Manny Araujo / Friday, July 31st, 2015 / Central Coast Health Watch, Latest news, Top Stories / Comments Off on New Cancer Center of Santa Barbara aims for better collaboration
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →
Latest
By Staff Report / Thursday, July 23rd, 2015 / Central Coast Health Watch, Latest news, Technology, Top Stories, Tri-County Public Companies / Comments Off on Amgen submits data on cancer drug Kyprolis to FDA
Thousand Oaks-based Amgen announced Thursday that it submitted data comparing its new multiple-myeloma drug against a rival to the Food and Drug Administration. Kyprolis is Amgen’s new treatment for multiple-myeloma, which is a form of blood cancer that forms in plasma cells and typically grows in bone marrow. The drug was approved for third-line treatments Read More →
Read More →
Latest
By Philip Joens / Friday, July 17th, 2015 / Central Coast Health Watch, Latest news, Technology, Top Stories / Comments Off on Amgen’s gamble on new cancer drug may pay off
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →
